Clinical trial
A Study of GW842166 in Adults With Osteoarthritis Pain
NCT00447486 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00447486 |
|---|---|
| Title | A Study of GW842166 in Adults With Osteoarthritis Pain |
| Official title | A Multicentre, Randomised, Double-Blind, Placebo and Naproxen (500mg) BID Controlled, Phase II Proof of Concept, Parallel Group Study to Assess the Efficacy and Safety of Oral GW842166 at Two Dose Levels Administered for 4 Weeks in Adults With Osteoarthritis of the Knee |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Knee |
| Intervention type | Drug |
| Interventions | GW842166 |
| Enrollment | 308 |
| Start date | Apr 1, 2007 |
| First posted | Mar 14, 2007 |
| Last update posted | May 18, 2009 |
| Countries | Denmark, Germany, Spain, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: